[ad_1]
Diabetic patients must continually monitor their glucose levels, which is why a therapeutic alternative has been created using medical technology. It consists of a small sensor inserted under the patient's skin, which measures glucose levels continuously, and which is connected to a transmitter. The device sends this data to an insulin pump and thus estimates the amount of insulin needed.
This feature allows patients to see the most relevant information in real time and set alerts and alarms to see when sensor glucose levels have fallen too low or become too high.
In addition to providing more accurate insulin intake and improving the quality of life of people with diabetes, it has been clinically proven that insulin pumps have better glucose control 1 which reduces the risk of complications of diabetes, such as: skin complications, hypertension problems, kidney damage, peripheral arterial disease, gastroparesis, osteoporosis and bone and joint problems, amputations, badual problems, urological problems, among others.
While it is true that insulin pump therapy is the most recommended therapeutic option for patients with type 1 diabetes, especially in children and adolescents, the Access to treatment is limited in Latin American countries, however, Colombia is the only country in which this therapy is covered by the Mandatory Health Plan (POS).
Due to social, economic, governmental, and legal barriers, in most South American countries, conventional treatment of multiple injections is still the most commonly used.
After Carolina Zárate diagnosed with type 1 diabetes since the age of 24, blogger and influencer in this pathology, the POS includes: insulin, glucometer per year, test strips and glucose lancets, insulin syringes, glucagon, drugs and oral pumps.
In many cases, the limitations that patients face in accessing treatment include: delays in drug delivery, lack of knowledge, and a small number of trained and authorized prescribers. insulin
In Colombia, insulin pumps are part of the mandatory plan however, it is necessary that patients provide for their needs. in medical equipment and insurers to facilitate access to this treatment.
Worldwide, diabetes costs are expected to rise to about $ 592 billion by 2035 . In 2013, expenditures for diabetes management accounted for 11% of the global health budget, according to WHO data.
In another of the studies conducted in Colombia, Dr. Ana María Gómez ] Specialist in Internal Medicine and Endocrinology, measured the cost-effectiveness of a more sensory insulin pump program among Type 1 diabetic patients, finding that the therapy increases the life time without complications, life expectancy, adjusted for the quality of life and, in addition, delayed the onset of complications.
Worldwide, recent publications show that insulin pump + sensor treatment and continuous monitoring compared to multiple injections treatment in hypoglycemic patients unnoticed decreases severe hypoglycemia by 59% and increases the time adequate blood sugar level of 17%.
It should be considered that the majority of patients The cost-effectiveness of insulin pump therapy is estimated on the direct costs generated by the treatment, but other indirect costs must be taken into account to measure the cost of treatment. economic impact of the disease.
These indirect costs refer to measurement aspects such as the cost for a mother to retire to take care of her child or how much it can cost a country a complication at a young age. 39, invalid for life
. Direct costs we could talk about a very cost effective therapy for health systems around the world.
[ad_2]
Source link
